Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Capivasertib Carcinoma Of Esophagus	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Exocrine Pancreatic Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Gastric Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Head And Neck Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Hematopoietic And Lymphoid Cell Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Renal Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Lung Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Uterine Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Prostate Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Rectal Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Skin Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Thyroid Gland Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Capivasertib Refractory Malignant Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Carboplatin Intrahepatic Cholangiocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Carboplatin Lung Superior Sulcus Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Cbx-12 Colorectal Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Cedazuridine Acute Myeloid Leukemia With Multilineage Dysplasia	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Prostate Neuroendocrine Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Endometrial Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Pancreatic Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Ovarian Mucinous Adenocarcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Cediranib Uterine Corpus Cancer	National Cancer Institute (NCI)	P2	CCC (53)
Ceralasertib Cancer	National Cancer Institute (NCI)	P2	CCC (53)

Showing 1151 to 1175 of 3,272 assets

PreviousPage 47 of 131Next